Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research

Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research

Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research

Salud

According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.



The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12% during (2019-2025).



The Myocardial Infarction market dominated the Global Cardiac Biomarkers Testing Market by Application in 2018, growing at a CAGR of 11 % during the forecast period. The Congestive Heart Failure market is expected to witness a CAGR of 12.5% during (2019-2025). Additionally, The Acute Coronary Syndrome market is expected to witness highest CAGR of 10.9% during (2019-2025).



The Laboratory Testing market dominated the Global Cardiac Biomarkers Testing Market by Location of Testing in 2018, growing at a CAGR of 10.3 % during the forecast period. The Point of Care Testing market is expected to witness highest CAGR of 13.6% during (2019-2025).



Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/



The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.



Global Cardiac Biomarkers Testing Market Segmentation



By Type



Creatine Kinase (CK-MB)



Troponins



Myoglobin



Natriuretic Peptides (BNP and NT-proBNP)



Ischemia Modified Albumin



Others



By Application



Myocardial Infarction



Congestive Heart Failure



Acute Coronary Syndrome



Atherosclerosis



Others



By Location of Testing



Point of Care Testing



Laboratory Testing



By Geography



North America



US



Canada



Mexico



Rest of North America



Europe



Germany



UK



France



Russia



Spain



Italy



Rest of Europe



Asia Pacific



China



Japan



India



South Korea



Singapore



Malaysia



Rest of Asia Pacific



LAMEA



Brazil



Argentina



UAE



Saudi Arabia



South Africa



Nigeria



Rest of LAMEA



Companies Profiled



Trivitron Healthcare Pvt. Ltd.



Abbott Laboratories



Siemens AG



Becton, Dickinson AND Company



Bio-Rad Laboratories, Inc.



Randox Laboratories Limited



Danaher Corporation



Thermo Fisher Scientific, Inc.



Johnson and Johnson



Quidel Corporation



Cardiac Biomarkers Testing Market Related Reports:



North America Market



Europe Market



Asia Pacific Market



LAMEA Market



 

KBV ResearchGlobal Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research
posicionamiento en buscadores
Vive Sex Shop - Tienda online de Juguetes eróticos